Component

Integrated real-time overdose registry

A current, shared picture of overdose events across a jurisdiction, so that response is not built on data that is a year old.

Why this exists

Most overdose data an agency acts on describes a period that has ended. Provisional national counts run months behind; final counts run longer. Meanwhile the local picture — which neighborhoods, which substances, which times, which services people did or did not reach — is scattered across emergency medical services, emergency departments, medical examiners, harm-reduction organizations and law enforcement, none of which sees the others’ data in useful time.

The consequence is that response allocation is done against last year’s pattern. Naloxone goes where overdoses were, outreach goes where outreach went, and the current cluster is invisible until it is historical.

How it works

  • Event-level intake, aggregate output. The registry ingests overdose events and publishes patterns — location, substance where known, time, outcome, service contact — at the level a response can act on.
  • Multiple contributors, one picture. The value is entirely in the integration; each contributor already has its own fragment.
  • Timeliness as the design constraint. A registry that is complete and three months late has failed at the only thing it was built for.
  • Linked to emerging threat analysis, so that a change in the pattern triggers a warning rather than a report.

What this is not

It is not a list of people who have overdosed, available to an agency. Outputs are aggregate.

It is not a law-enforcement resource. A registry that people believe is one stops receiving accurate data almost immediately — from harm-reduction organizations first, and they are frequently the best source in it.

It is not a substitute for the state and federal reporting a jurisdiction is already obliged to do. It is a faster operational picture alongside them.

Whether and how a given agency may collect, hold and share overdose event data — and under which confidentiality regimes — is a determination for that agency and its counsel. IntellaRx describes what the registry does and what it holds; it does not advise anyone on their own legal position. See data governance.

Sources

Every figure on this page is traceable to the source listed here.

  • Tanz LJ, Stewart A, Gladden RM, Ko JY, Owens L, O’Donnell J. Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths — United States, 2021–2024. MMWR Morb Mortal Wkly Rep. 2024;73(48):1099–1105. PMID 39636782. View source.
  • National Center for Health Statistics. VSRR Provisional Drug Overdose Death Counts (dataset xkb8-kh2a), 12-month-ending counts for the United States. Data accessed 20 August 2026. View source.